GLP-1 amplifies insulin signaling by up-regulation of IRbeta, IRS-1 and Glut4 in 3T3-L1 adipocytes
- PMID: 17992607
- DOI: 10.1007/s12020-007-9011-4
GLP-1 amplifies insulin signaling by up-regulation of IRbeta, IRS-1 and Glut4 in 3T3-L1 adipocytes
Abstract
Glucagon-like peptide-1 (7-36) amide (GLP-1) is an insulin secretagogue. Recently, many studies have shown GLP-1 can improve insulin resistance in peripheral tissues. In the present study, we investigated glucose uptake in 3T3-L1 adipocytes in either basal or insulin resistant state and dissected insulin signaling pathway in order to elucidate the molecular mechanisms of GLP-1 mediated improvement of insulin resistance. We found GLP-1 and its long lasting analogue, exendin 4 up-regulated basal IR, IRS-1 and Glut 4 expressions although they did not increase basal glucose uptake alone. However, GLP-1 and exendin-4 increased insulin mediated glucose uptake in intact and TNF-alpha treated 3T3-L1 adipocytes by up-regulation of phophorylated IRbeta, IRS-1, Akt and GSK-3beta. These results indicate that GLP-1 and its analogue exendin-4 can amplify insulin signaling in 3T3-L1 adipocytes by up-regulation of some crucial insulin signaling molecules.
Similar articles
-
Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions.J Mol Endocrinol. 1997 Dec;19(3):241-8. doi: 10.1677/jme.0.0190241. J Mol Endocrinol. 1997. PMID: 9460645
-
Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes.J Cell Physiol. 1997 Sep;172(3):275-83. doi: 10.1002/(SICI)1097-4652(199709)172:3<275::AID-JCP1>3.0.CO;2-L. J Cell Physiol. 1997. PMID: 9284947
-
Tumor necrosis factor (TNF)-α-induced repression of GKAP42 protein levels through cGMP-dependent kinase (cGK)-Iα causes insulin resistance in 3T3-L1 adipocytes.J Biol Chem. 2015 Feb 27;290(9):5881-92. doi: 10.1074/jbc.M114.624759. Epub 2015 Jan 13. J Biol Chem. 2015. PMID: 25586176 Free PMC article.
-
Novel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates.Cell Mol Life Sci. 2013 Aug;70(16):2815-34. doi: 10.1007/s00018-012-1176-1. Epub 2012 Oct 10. Cell Mol Life Sci. 2013. PMID: 23052216 Free PMC article. Review.
-
Insulin Signaling in Arthritis.Front Immunol. 2021 Apr 30;12:672519. doi: 10.3389/fimmu.2021.672519. eCollection 2021. Front Immunol. 2021. PMID: 33995414 Free PMC article. Review.
Cited by
-
Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model.Endocrinol Metab (Seoul). 2021 Feb;36(1):157-170. doi: 10.3803/EnM.2020.781. Epub 2021 Feb 24. Endocrinol Metab (Seoul). 2021. PMID: 33677937 Free PMC article.
-
Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms.Oxid Med Cell Longev. 2021 Apr 27;2021:9959320. doi: 10.1155/2021/9959320. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34007411 Free PMC article. Review.
-
EFFECTS OF EXENDIN-4 ON ENDOPLASMIC RETICULUM STRESS-MEDIATED INSULIN RESISTANCE IN 3T3-L1 ADIPOCYTES.Acta Endocrinol (Buchar). 2019 Apr-Jun;15(2):158-164. doi: 10.4183/aeb.2019.158. Acta Endocrinol (Buchar). 2019. PMID: 31508171 Free PMC article.
-
Role of adipose tissue GLP-1R expression in metabolic improvement after bariatric surgery in patients with type 2 diabetes.Sci Rep. 2019 Apr 18;9(1):6274. doi: 10.1038/s41598-019-42770-1. Sci Rep. 2019. PMID: 31000783 Free PMC article. Clinical Trial.
-
Glucagon-like peptide-1 receptor agonist reduces di(2-ethylhexyl) phthalate-induced atherosclerotic processes in vascular smooth muscle cells.Physiol Res. 2020 Dec 22;69(6):1095-1102. doi: 10.33549/physiolres.934480. Epub 2020 Nov 2. Physiol Res. 2020. PMID: 33129247 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical